Ceribell, Inc. (CBLL)
Ceribell, Inc. (CBLL) from its SEC filings: 2025 revenue $89.1 million (+36% vs the year before), net margin -60%, free cash flow -$41.6 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Electromedical & Electrotherapeutic Apparatus |
| Revenue (2025) | $89.1 million |
| Revenue growth | +36% |
| Net income | -$53.4 million |
| Net margin | -60.0% |
| Free cash flow | -$41.6 million |
| Diluted EPS | $-1.46 |
| Latest quarter (Q2 2026 (calendar)) revenue vs a year earlier | +32% |
| Cash | $32.7 million |
| Share count, 1 year | +5% |
| Fundamentals check | Mixed fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-10-24. Education only, not financial advice.